Through recent research advances we are increasingly able to understand and address immune-mediated diseases. Biotechnology is yielding success in areas with a strong immunologic component, such as allergic asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis and multiple sclerosis. Nevertheless, the burden of immune-mediated diseases is still enormous, with direct and indirect costs associated with such conditions believed to exceed $100 billion in the USA alone. Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 3.9 |
| 2022 | 4.4 |
| 2021 | 5.124 |
Expert Review of Clinical Immunology, 1744-666X, 2006-ongoing, Immunology and Microbiology,Medicine.